Cumulative head-impact frequency and magnitude per player higher for live drills among adolescent football players
THURSDAY, Oct. 13, 2022 (HealthDay News) — For adolescent football players, head impact exposure increases as level of contact increases, with higher cumulative head-impact frequency and magnitude with live drills, according to a study published online Oct. 13 in Pediatrics.
Kyle A. Kercher, Ph.D., from the School of Public Health-Bloomington at Indiana University, and colleagues conducted a prospective, multisite study in one season involving 74 players from three high school football teams. Each of the players wore a sensor-installed mouthguard, which monitored head-impact frequency, peak linear acceleration, and peak rotational acceleration.
A total of 7,312 impacts were recorded, with a per-player median of 67 impacts. The researchers found increases in head-impact outcomes by level of contact after controlling for duration (air < bags < control < thud < live). Cumulative head-impact frequency and magnitude per player were higher for live drills than other levels. The lowest cumulative frequency and magnitude were seen for air drills.
“Empirical support for the levels-of-contact system in the current study provides further evidence that the system may present a practical means to regulate head-impact exposure,” the authors write. “The study results point to the importance of continued research dissecting the structural elements of football practice, such as intensity level, to determine practical, feasible, and scalable approaches to minimizing head-impact exposure while maintaining tackle football as a viable physical activity opportunity.”
Abstract/Full Text (subscription or payment may be required)
EHR-Enabled QI Intervention Improves Chlamydia, Gonorrhea Screening in Teens
CTE Pathology Found in Nearly 75 Percent of Deceased Former NFL Players
Early Survivorship Care Linked to Improved Outcomes in Head, Neck Cancer
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Rates of Drug Use-Associated Infective Endocarditis Declined From 2020 to 2022
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Withdrawal From Medetomidine Increasingly Seen in ICUs